Literature DB >> 22236427

DOCK8 deficiency.

Helen C Su1, Huie Jing, Qian Zhang.   

Abstract

The discovery that loss-of-function mutations in the gene DOCK8 are responsible for most forms of autosomal recessive hyper-IgE syndrome and some forms of combined immunodeficiency without elevated serum IgE has led to studies into the immunopathogenesis of this disease. In this review, we relate the clinical features of this disease to studies using patients' cells and a mouse model of Dock8 deficiency, which have revealed how DOCK8 regulates T and B cell numbers and functions. The results of these studies help to explain how the absence of DOCK8 contributes to patients' susceptibility to viral, fungal, and bacterial infections. However, unanswered questions remain regarding how the absence of DOCK8 also leads to high IgE and allergic disease, predisposition for malignancy, and unusual clinical features, such as CNS abnormalities and autoimmunity, observed in some patients.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22236427     DOI: 10.1111/j.1749-6632.2011.06295.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  32 in total

1.  Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait.

Authors:  Waleed Al-Herz; Raj Ragupathy; Michel J Massaad; Raja'a Al-Attiyah; Arti Nanda; Karin R Engelhardt; Bodo Grimbacher; Luigi Notarangelo; Talal Chatila; Raif S Geha
Journal:  Clin Immunol       Date:  2012-03-30       Impact factor: 3.969

2.  Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation.

Authors:  Sevgi Keles; Louis Marie Charbonnier; Venkataraman Kabaleeswaran; Ismail Reisli; Ferah Genel; Nesrin Gulez; Waleed Al-Herz; Narayanaswamy Ramesh; Antonio Perez-Atayde; Neslihan E Karaca; Necil Kutukculer; Hao Wu; Raif S Geha; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2016-05-24       Impact factor: 10.793

3.  Additional diverse findings expand the clinical presentation of DOCK8 deficiency.

Authors:  Ozden Sanal; Huie Jing; Tuba Ozgur; Deniz Ayvaz; Dara M Strauss-Albee; Sibel Ersoy-Evans; Ilhan Tezcan; Gulten Turkkani; Helen F Matthews; Goknur Haliloglu; Aysel Yuce; Bilgehan Yalcin; Ozay Gokoz; Kader K Oguz; Helen C Su
Journal:  J Clin Immunol       Date:  2012-04-04       Impact factor: 8.317

4.  Low immunoglobulin E flags two distinct types of immune dysregulation.

Authors:  M Elkuch; V Greiff; C T Berger; M Bouchenaki; T Daikeler; A Bircher; A A Navarini; I Heijnen; M Recher
Journal:  Clin Exp Immunol       Date:  2017-01-11       Impact factor: 4.330

Review 5.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

Review 6.  Atopic Dermatitis and Allergic Urticaria: Cutaneous Manifestations of Immunodeficiency.

Authors:  Martin Robert Gaudinski; Joshua D Milner
Journal:  Immunol Allergy Clin North Am       Date:  2016-10-28       Impact factor: 3.479

7.  HkRP3 is a microtubule-binding protein regulating lytic granule clustering and NK cell killing.

Authors:  Hyoungjun Ham; Walter Huynh; Renee A Schoon; Ronald D Vale; Daniel D Billadeau
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

8.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

Review 9.  The multiple faces of leukocyte interstitial migration.

Authors:  Tim Lämmermann; Ronald N Germain
Journal:  Semin Immunopathol       Date:  2014-02-27       Impact factor: 9.623

Review 10.  Recent Advances in DOCK8 Immunodeficiency Syndrome.

Authors:  Qian Zhang; Huie Jing; Helen C Su
Journal:  J Clin Immunol       Date:  2016-05-20       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.